Orexigen Therapeutics, Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2015-06-30 3 months ending 2015-03-31 3 months ending 2014-12-31 3 months ending 2014-09-30 3 months ending 2014-06-30
Revenue 5.19 4.36 22.95 30.86 0.86
Other Revenue, Total - - - - -
Total Revenue 5.19 4.36 22.95 30.86 0.86
Cost of Revenue, Total - - - - -
Gross Profit - - - - -
Selling/General/Admin. Expenses, Total 10.81 8.58 7.60 7.10 6.93
Research & Development 15.11 11.24 12.97 10.72 16.73
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - - - - -
Other Operating Expenses, Total - - - - -
Total Operating Expense 25.92 19.83 20.57 17.82 23.66
Operating Income -20.73 -15.47 2.38 13.04 -22.80
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net - - - - -
Income Before Tax -22.50 -17.23 0.61 11.27 -24.51
Income After Tax -22.50 -17.23 0.61 11.27 -24.51
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -22.50 -17.23 0.61 11.27 -24.51
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -22.50 -17.23 0.61 11.27 -24.51
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -22.50 -17.23 0.61 11.27 -24.51
Income Available to Common Incl. Extra Items -22.50 -17.23 0.61 11.27 -24.51
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - - 0.00
Diluted Weighted Average Shares 125.19 123.88 123.00 130.14 117.99
Diluted EPS Excluding Extraordinary Items -0.18 -0.14 0.00 0.09 -0.21
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 - 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.18 -0.14 0.00 0.09 -0.21